PROC
Clinical trials for PROC explained in plain language.
Never miss a new study
Get alerted when new PROC trials appear
Sign up with your email to follow new studies for PROC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first human study of a new experimental cancer drug called HWK-007. Researchers are testing it in adults with advanced ovarian, endometrial, or non-small cell lung cancers that have stopped responding to standard treatments. The main goals are to find the safest dose …
Matched conditions: PROC
Phase: PHASE1 • Sponsor: Whitehawk Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
First patients test promising new weapon against tough gynecologic cancers
Disease control Recruiting nowThis is the first-ever study in people of a new targeted cancer drug called HWK-016. It aims to find a safe and effective dose for adults with advanced ovarian or endometrial cancer that has spread or come back. The study will test the drug alone and in combination with another c…
Matched conditions: PROC
Phase: PHASE1 • Sponsor: Whitehawk Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC